Epilepsy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Department of Neurology, Jefferson Comprehensive Epilepsy Center, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
J Med Virol. 2022 Mar;94(3):979-984. doi: 10.1002/jmv.27404. Epub 2021 Oct 24.
We investigated the frequency of brain fog in a large cohort of patients with documented coronavirus disease-2019 (COVID-19) who have survived the illness. We also scrutinized the potential risk factors associated with the development of brain fog. Adult patients (18-55 years of age), who were referred to the healthcare facilities anywhere in Fars province from February 19, 2020 to November 20, 2020 were included. All patients had a confirmed COVID-19 diagnosis. In a phone call, at least 3 months after their discharge from the hospital, we obtained their current information. A questionnaire was specifically designed for data collection. In total, 2696 patients had the inclusion criteria; 1680 (62.3%) people reported long COVID syndrome (LCS). LCS-associated brain fog was reported by 194 (7.2%) patients. Female sex (odds ratio [OR]: 1.4), respiratory problems at the onset (OR: 1.9), and intensive care unit (ICU) admission (OR: 1.7) were significantly associated with reporting chronic post-COVID "brain fog" by the patients. In this large population-based study, we report that chronic post-COVID "brain fog" has significant associations with sex (female), respiratory symptoms at the onset, and the severity of the illness (ICU admission).
我们调查了在大量有记录的新冠肺炎(COVID-19)幸存患者中,脑雾的发生频率。我们还仔细研究了与脑雾发展相关的潜在危险因素。
本研究纳入了 2020 年 2 月 19 日至 2020 年 11 月 20 日期间来自法尔斯省各地医疗机构的 18-55 岁成年患者。所有患者均确诊为 COVID-19。在患者出院至少 3 个月后,我们通过电话获得了他们的现状信息。专门设计了一份问卷进行数据收集。
共有 2696 例患者符合纳入标准,其中 1680 例(62.3%)患者报告了长新冠综合征(LCS)。194 例(7.2%)患者报告了 LCS 相关的脑雾。女性(比值比 [OR]:1.4)、发病时存在呼吸道问题(OR:1.9)和入住重症监护病房(ICU)(OR:1.7)与患者报告慢性新冠后“脑雾”显著相关。
在这项基于人群的大型研究中,我们报告慢性新冠后“脑雾”与性别(女性)、发病时的呼吸道症状和疾病严重程度(入住 ICU)显著相关。
J Med Virol. 2022-3
Eur Neurol. 2023
Iran J Med Sci. 2021-11
World J Pediatr. 2021-10
Neurol Neurochir Pol. 2023
Emerg Infect Dis. 2023-5
BMC Infect Dis. 2025-4-18
BMC Public Health. 2025-4-1
Eur J Neurol. 2025-3
Psychol Res Behav Manag. 2025-3-12
Clin Microbiol Infect. 2021-10
J Biol Regul Homeost Agents. 2021
Healthcare (Basel). 2021-5-13
Eur Neuropsychopharmacol. 2021-5
Int J Obes (Lond). 2021-6
Nat Med. 2021-4